MJTV news MJ Biotech, Inc. Signs Letter of Intent for the Acquisition of a Hemp Based CBD Extraction Laboratory GlobeNewswire "Press Releases"
Cheyenne, WY , Feb. 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- (OTC: MJTV)MJ Biotech, Inc.(f/k/a Michael James Enterprises, Inc. ) has a fully executed Letter of Intent to acquire a California based extraction laboratory producing HEMP based Cannabidiol (CBD) oil.
This acquisition will provideMJ Biotech, Inc. the CBD oil required to produce its CBD infused Teas and Herbs. It will also allow MJ Biotech, Inc. to supply CBD oil to its current wholesale customer base. Once acquired, the Company plans on adding additional equipment to double its current CBD oil production.
CBD is extracted from the flowers and buds of the hemp plants. It does not produce intoxication; marijuana's "high" is caused by the chemical tetrahydrocannabinol (THC). Some of the benefits of CBD: it can reduce pain, relieve depression and anxiety, and promote heart health to name a few.
About MJ Biotech, Inc.
With a missionand commitmentto promote health and wellness, MJ BIOTECH, INC. , is diligently seeking new Commercialopportunities and relationships. These excitingnew avenues range from the Medical Cannabissector to healthy lifestyle products.
It is the MJBIOTECH, INC., goal to not only promoteand provideproducts for the public good, but to always remember our prime directive is that of enhancing Shareholder value.
We believewe can achieveboth of these objectives by promoting positive lifestyle choices in the Commercialrelationshipsthat we create, foster and support.
For additional information please go tohttps://mjbiotech.us/
Safe Harbor Statement
This release contains forward-looking statements, which are made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are commonly identified by words such as "would," "may," "will," "expects," and other terms with similar meaning. Forward-looking statements are based on current beliefs, assumptions and expectations and speak only as of the date of this release and involve risks and uncertainties that could cause actual results to differ materially from current expectations. We assume no obligation to update or revise any forward-looking statement, whether because of new information, future events or any other reason.
For additional information please contact us via email atinfo@mjbiotech.us
Source: MJ Biotech, Inc.
Cheyenne, WY , Feb. 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- (OTC: MJTV)MJ Biotech, Inc.(f/k/a Michael James Enterprises, Inc. ) has a fully executed Letter of Intent to acquire a California based extraction laboratory producing HEMP based Cannabidiol (CBD) oil.
This acquisition will provideMJ Biotech, Inc. the CBD oil required to produce its CBD infused Teas and Herbs. It will also allow MJ Biotech, Inc. to supply CBD oil to its current wholesale customer base. Once acquired, the Company plans on adding additional equipment to double its current CBD oil production.
CBD is extracted from the flowers and buds of the hemp plants. It does not produce intoxication; marijuana's "high" is caused by the chemical tetrahydrocannabinol (THC). Some of the benefits of CBD: it can reduce pain, relieve depression and anxiety, and promote heart health to name a few.
About MJ Biotech, Inc.
With a missionand commitmentto promote health and wellness, MJ BIOTECH, INC. , is diligently seeking new Commercialopportunities and relationships. These excitingnew avenues range from the Medical Cannabissector to healthy lifestyle products.
It is the MJBIOTECH, INC., goal to not only promoteand provideproducts for the public good, but to always remember our prime directive is that of enhancing Shareholder value.
We believewe can achieveboth of these objectives by promoting positive lifestyle choices in the Commercialrelationshipsthat we create, foster and support.
For additional information please go tohttps://mjbiotech.us/
Safe Harbor Statement
This release contains forward-looking statements, which are made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are commonly identified by words such as "would," "may," "will," "expects," and other terms with similar meaning. Forward-looking statements are based on current beliefs, assumptions and expectations and speak only as of the date of this release and involve risks and uncertainties that could cause actual results to differ materially from current expectations. We assume no obligation to update or revise any forward-looking statement, whether because of new information, future events or any other reason.
For additional information please contact us via email atinfo@mjbiotech.us
Source: MJ Biotech, Inc.
